Nanobiotix S.A.
NBTXNASDAQHealthcare● Active
$35.88
+$0.42(+1.18%)
Market Cap$1.8B
P/E Ratio—
52W High$57.14
52W Low$4.18
Nanobiotix S.A. (NBTX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NBTX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $29.64M | ($7.19M) | $36.21M | $4.78M | $2.65M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $29.64M | ($7.19M) | $36.21M | $4.78M | $2.65M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $23.11M | $40.54M | $38.40M | $32.64M | $30.38M |
| G&A Expenses | $20.22M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $40.46M | $61.20M | $62.99M | $51.48M | $55.23M |
| Operating Income | ($10.82M) | ($68.39M) | ($26.78M) | ($46.70M) | ($52.58M) |
| Operating Margin %(computed) | -36.49% | 951.21% | -73.96% | -977.85% | — |
| Interest Income | $0.98M | $2.63M | $1.22M | $0.26M | $0.00M |
| Interest Expense | $10.39M | $8.09M | $7.98M | $5.84M | $0.70M |
| Income Before Tax | ($23.96M) | ($68.03M) | ($39.58M) | ($57.03M) | ($47.00M) |
| Income Tax Expense | $0.00M | $0.10M | $0.12M | $0.01M | $0.01M |
| Net Income | ($23.96M) | ($68.13M) | ($39.70M) | ($57.04M) | ($47.00M) |
| Net Margin %(computed) | -80.83% | 947.59% | -109.64% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.50 | $-1.44 | $-1.08 | $-1.64 | $-1.35 |
| Wtd Avg Shares | 47.82M | 47.27M | 36.76M | 34.85M | 34.73M |
| EBITDA | ($12.07M) | ($67.67M) | ($23.69M) | ($44.22M) | ($45.60M) |
| EBITDA Margin %(computed) | -40.71% | 941.11% | -65.42% | -925.82% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · M
Explore more Nanobiotix S.A. data
About Nanobiotix S.A. (NBTX) Income Statement
Nanobiotix S.A. (NBTX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NBTX reported revenue of $0.03B, gross profit of $0.03B (gross margin 100.00%), and net income of ($0.02B) — a net profit margin of -80.83%.
Frequently asked questions
NBTX · 4 questionsNanobiotix S.A. (NBTX) reported revenue of $0.03B for 2025, up 512.3% year-over-year.
NBTX revenueNBTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08